glp-1 agonist indications GLP1 medicines now address weight loss and other health conditions through innovative formulations and expanded indications, highlighting key questions about their efficacy and safety. https://ja.ma/3JZg8l3 Benefits and Risks of GLP-1

Ozempic was (and still is) not FDA-approved for weight loss in patients without diabetes

Fatty liver disease can cause liver inflammation and damage that can progress into cirrhosis

Brand-name Contrave runs $200-300 per month, though the individual components (generic bupropion and naltrexone) can be prescribed separately for significantly less

Obesity is more than a number on the scale: your fat cells act like mini chemical factories, pumping out molecules such as IL-6, TNF-alpha, and IL-17 that keep your immune system stuck in attack mode

Documented Outcomes Prescription semaglutide and tirzepatide have undergone Phase 3 randomized controlled trials demonstrating average weight loss of 10-22 percent over 68 weeks